Squamous cell transformation and EGFR T790M mutation as acquired resistance mechanisms in a patient with lung adenocarcinoma treated with a tyrosine kinase inhibitor: A case report.
Oncology Letters
Bruno, Rossella R; Proietti, Agnese A; Alì, Greta G; Puppo, Gianfranco G; Ribechini, Alessandro A; Chella, Antonio A; Fontanini, Gabriella G
Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial.
British Journal Of Cancer
Pinder, S E SE; Campbell, A F AF; Bartlett, J M S JM; Marshall, A A; Allen, D D; Falzon, M M; Dunn, J A JA; Makris, A A; Hughes-Davies, L L; Stein, R C RC
Multiplication of Chromosome 17 Centromere Is Associated with Prognosis in Patients with Invasive Breast Cancers Exhibiting Normal HER2 and TOP2A Status.
Journal Of Breast Cancer
Kim, Aeri A; Shin, Hyung Chan HC; Bae, Young Kyung YK; Kim, Min Kyoung MK; Kang, Su Hwan SH; Lee, Soo Jung SJ; Lee, Eun Hee EH